Live
- BJP releases ‘charge sheet’ against BJD govt
- District Nodal Officer Venkataramana announced the intermediate results
- She team that stopped child marriages
- Medical devices sector needs separate rules, says industry body AiMeD
- Andhra Paper declares lockout
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
New Delhi: Biocon Q3 net dips 7%
Highlights
Biotechnology major Biocon on Thursday reported a 6.62 per cent fall in consolidated net profit at Rs 202.8 crore for the quarter ended December 31, 2019 due to higher research and development (R&D) expenses and tax impact of an exceptional item.
New Delhi: Biotechnology major Biocon on Thursday reported a 6.62 per cent fall in consolidated net profit at Rs 202.8 crore for the quarter ended December 31, 2019 due to higher research and development (R&D) expenses and tax impact of an exceptional item.
The company had posted a net profit of Rs 217.2 crore during October-December period of the previous fiscal, Biocon said in a filing to the BSE. The company's consolidated revenue from operations, however, rose to Rs 1,748.1 crore for the quarter under consideration as against Rs 1,540.8 crore in the same period a year ago. Its expenses rose to Rs 1,465.6 crore for the quarter ended December 2019 as against Rs 1,295.4 crore in the year-ago period.
Next Story
ADVERTISEMENT
